共 277 条
[1]
Van den Berghe G(2006)Intensive insulin therapy in the medical ICU New Engl J Med 354 449-61
[2]
Wilmer A(2012)Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis New Engl J Med 367 124-34
[3]
Hermans G(2012)Drotrecogin alfa (activated) in adults with septic shock New Engl J Med 366 2055-64
[4]
Meersseman W(2015)A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators Int Care Med 41 1549-60
[5]
Wouters PJ(2010)Epidemiology of traumatic deaths: comprehensive population-based assessment World J Surg 34 158-63
[6]
Milants I(2005)Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials J Trauma 59 8-15
[7]
Perner A(2010)Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage J Trauma 69 489-500
[8]
Haase N(2011)Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications Ann Intern Med 154 529-40
[9]
Guttormsen AB(2015)Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial JAMA 313 471-82
[10]
Tenhunen J(2010)We should abandon randomized controlled trials in the intensive care unit Crit Care Med 38 S534-8